PACAP-38 is a chemorepellent and an agonist for the lysozyme receptor in Tetrahymena thermophila

被引:0
|
作者
S. R. Mace
J. G. Dean
J. R. Murphy
J. L. Rhodes
H. G. Kuruvilla
机构
[1] Cedarville College,
[2] Department of Science and Mathematics,undefined
[3] PO Box 601,undefined
[4] Cedarville,undefined
[5] OH 45314,undefined
[6] USA e-mail: kuruvilh@cedarville.edu Tel.: +1-937-766-7606; Fax: +1-937-766-7631,undefined
来源
Journal of Comparative Physiology A | 2000年 / 186卷
关键词
Key words Chemorepellent; PACAP-38; Tetrahymena; Chemosensory transduction; Behavioral adaptation;
D O I
暂无
中图分类号
学科分类号
摘要
Pituitary adenylate cyclase activating peptide (PACAP-38) is a peptide hormone which functions in many mammalian systems, including the nervous and digestive systems. Using in vivo behavioral studies, we have found that this hormone functions as a chemorepellent in Tetrahymena thermophila with an EC50 of 10 nM. Cells previously adapted to PACAP-38 were found to be adapted to lysozyme, and vice versa. Furthermore, the in vivo behavioral activity of PACAP-38 was blocked by addition of the anti-lysozyme receptor antibody, 5545. Chemorepellent activity of PACAP-38 was also inhibited by the addition of neomycin sulfate (inhibition constant Ki=0.080 μmol · l−1), a competitive inhibitor of lysozyme binding to its receptor. PACAP-38 is a more potent and specific agonist for the lysozyme receptor than either intact lysozyme or CB2, a 24-amino acid fragment of lysozyme.
引用
收藏
页码:39 / 43
页数:4
相关论文
共 50 条
  • [21] Peripheral antinociceptive effect of PACAP-38 in rats and mice
    Sandor, Katalin
    Boelcskei, Kata
    Elekes, Krisztian
    Pinter, Erika
    Petho, Gabor
    Reglodi, Dora
    Szolcsanyi, Janos
    Helyes, Zsuzsanna
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2007, 33 (03) : 340 - 341
  • [22] Quantitative analysis of PACAP-38 and amyloid beta composition using a dual reaction in reduced graphene oxide biosensor to verify the neuroprotective role of PACAP-38
    Lee, Seungjun
    Song, Hyo Ryeong
    Park, Keunwan
    Lee, Minhyeong
    Lee, A-Hyeon
    Roh, Seung Min
    Park, Yejin
    Kim, Hye Jin
    Kwon, Youngeun
    Yang, Seung-Hoon
    Kim, Jinsik
    SENSORS AND ACTUATORS B-CHEMICAL, 2022, 361
  • [23] Effect of intestinal cold preservation in PACAP-38 containing solution
    Ferencz, A.
    Szabo, Gy
    Csukas, D.
    Seres, L.
    Feher, D.
    Sandor, J.
    Reglodi, D.
    Jancso, G.
    Kovacs, K.
    Weber, Gy
    ACTA PHYSIOLOGICA, 2014, 211 : 166 - 166
  • [24] Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide
    Champion, HC
    Santiago, JA
    Garrison, EA
    Cheng, DY
    Coy, DH
    Murphy, WA
    Ascuitto, RJ
    RossAscuitto, NT
    McNamara, DB
    Kadowitz, PJ
    VIP, PACAP, AND RELATED PEPTIDES, 2ND INTERNATIONAL SYMPOSIUM, 1996, 805 : 429 - 442
  • [25] CYTOKINE MEASUREMENTS AFTER PACAP-38 CONTAINING INTESTINAL TRANSPLANTATION
    Ferencz, A.
    Nedvig, K.
    Weber, Gy
    Kovacs, K.
    Toth, G.
    Reglodi, D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S207 - S207
  • [26] Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats
    Telegdy, G.
    Adamik, A.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 281 : 333 - 338
  • [27] Intestinal cold storage in PACAP-38 containing preservation solution
    Ferencz, A.
    Nedvig, K.
    Gy, Weber
    Nemeth, J.
    Kiss, P.
    Reglodi, D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 : S168 - S168
  • [28] C-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptor
    Emery, Andrew C.
    Alvarez, Ryan A.
    Abboud, Philip
    Xu, Wenqin
    Westover, Craig D.
    Eiden, Maribeth V.
    Eiden, Lee E.
    PEPTIDES, 2016, 79 : 39 - 48
  • [29] PACAP-38 protects cerebellar granule cells from apoptosis
    Journot, L
    Villalba, M
    Bockaert, J
    VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM, 1998, 865 : 100 - 110
  • [30] Evidence for pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP1 receptor in human skin: PACAP-38 is increased in psoriasis patients.
    Steinhoff, M
    McGregor, GP
    Steinhoff, A
    Fahrenkrug, J
    Schmidt, WE
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 408 - 408